Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > New positions

<< Previous

Bullboard Posts

Next >>

Comment by longterm56on Nov 30, 2021 11:30pm

134 Views

Post# 34183463

RE:RE:RE:RE:RE:New positions

I suspect that they know who they want (probably from Pfizer) and had to create a significant position for him/her. It will likely be filled rather quickly. Just a guess. -LT

Wino115 wrote: I'd agree with this assessment. That CoS is really only seen in fairly large companies, so it's definitely a Pfizer influenced idea. But if a company becomes more complex, there's a lot of the day-to-day stuff that needs to be executed and often the guy at the top gets called on to make every silly little decision. Just the requests clog up the inbox. So to offload the day-to-day and function-oriented decision's to allow the CEO to spend a lot more time on strategy, board, key developments and the big value-driving factors beyond just the execution can be helpful. Not that I've been a CEO, but anyone who's managed more than 20 people knows there's a tax on your time to answer loads of less important issues.

Given we all know how conservative and budget oriented the Board is, I have to believe that they wouldn't be doing this kind of bulking up without having a very high degree of confidence in the direction they are moving. They just wouldn't take on all those long-term expenses without knowing it won't crush their cash balance. It's also on the expensive side to layoff in Canada, so you don't hire without believing they are long term hires. We saw what happend when they canned the PR guy -- lots of severence and a lawsuit for more.

realitycheck4u wrote: I am going out on a limb here and saying that there is a very big role with Chief of Staff with tthe way that role is worded. Does that mean our CEO is about to be way too busy with mundane tasks that are not about the tough job of negotiating, partnering and Selling the big picture to analysts and investors. This new job is essentially the CEO's job of a company that is not drinking from the firehose. So, I think if we're about to hire a chief of staff, then we may see some incredible things break out soon.

palinc2000 wrote:
I am a bit surprised to see a Chief Of Staff amongst the new positions.The job description appears to include a lot of tasks usually performed by the CEO.... I have never seen that in such a small and even much bigger companies...

There has to be another shoe to drop....

archeo753 wrote: It seems like Paul has very grand plans for the future. He definitely is building Thera into a much more substantial company than it was before he took the reigns. Hopefully, it is based on confidence in the future of the pipeline but regardless, whatever happens with the cancer trials, Theratechnologies is a much stronger company than it was a year ago.

Bucknelly21 wrote: Thera posted 4 new positions today, if I were reading between the lines I would think that things are going well, just a thought